The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease

Hepatology Research

Volumn 33, Issue 2, 2005, Pages 72-76

  Hashimoto, Etsuko ^a   Yatsuji, Saturu ^a   Kaneda, Hiroyuki ^a   Yoshioka, Yoko ^a   Taniai, Makiko ^a   Tokushige, Katsutoshi ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Natural history; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

AMINOTRANSFERASE; HYALURONIC ACID;

ADOLESCENT; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS; HISTOPATHOLOGY; HUMAN; JAPAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SCHOOL CHILD; SCREENING TEST; SEX DIFFERENCE; STEATOSIS;

EID: 29144458866     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.09.007     Document Type: Article

References (20)

1. J. Ludwig T.R. Viggiano D.B. McGill B.J. Ott Nonalcoholic steatohepatitis Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434-438
2. E.E. Powel W. Cooksley WGE R. Hanson J. Searle J.W. Halliday L.W. Powell The natural history of steatohepatitis: A follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74-80
3. C.A. Matteoni Z.M. Younossi T. Gramlich et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity Gastroenterology 116 1999 1413-1419
4. I.R. Willner B. Waters S.R. Patil A. Reuben J. Morelli C.A. Riely Ninety patients with nonoalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 10 2001 2957-2961
5. P. Angulo J.C. Keach K.P. Batts K.D. Lindor Risk factors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356-1362
6. M. Shimada E. Hashimoto H. Kaneda S. Noguchi N. Hayashi Nonalcoholic steatohepatitis: Risk factors for liver fibrosis Hepatol Res 24 2002 429-438
7. Y. Yoshioka E. Hashimoto H. Kaneda et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma and burnt-out NASH J Gastroenterol 39 2004 1215-1218
8. E. Hashimoto M. Taniai H. Kaneda et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis Alcohol: Clin Exp Res 28 2004 164S-168S
9. M. Shimada E. Hashimoto M. Taniai et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis J Hepatol 37 2002 154-160
10. Y. Zen K. Katayanagi K. Tsunyama K. Harada I. Araki Y. Nakanuma Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathol Int 51 2001 127-131
11. H.P. Cotrim R. Parana E. Braga L. Lyra Nonalcoholic steatohepatitis and hepatocellular carcinoma: Natural history? Am J Gastroenterol 95 2000 3018-3019
12. E. Bugianesi N. Leone E. Vanni et al. Expanding the natural history of NASH: From cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134-140
13. J.A. Marrero R. Fontana G.L. Su H.S. Conjeevaram D.M. Emick A.S. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349-1354
14. V. Ratziu L. Bonyhay V. Di Martino et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485-1493
15. B.A. Neuschwander-Tetri S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202-1219
16. A.J. Sanyal AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 2002 1705-1725
17. E.M. Brunt C.G. Janney A.M. Di Bisceglie et al. Nonalcoholic steato hepatitis: A proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467-2474
18. E.M. Brunt Nonalcoholic steatohepatitis Sem Liver Dis 24 2004 3-18
19. H. Kaneda E. Hashimoto Y. Yoshioka et al. Serum marker can predict both advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease Hepatology 40 Suppl 1 2004 588A
20. S. Chitturi M. Weltman G.C. Farrell et al. HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity Hepatology 36 2002 142-149